Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Oncology Molecular Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • GLO2772340
  • 0 Pages
  • September 2018
  • Medical Devices
Download Sample    Get Discount   
 
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.

Scope of the Report:

This report studies the Oncology Molecular Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncology Molecular Diagnostics market by product type and applications/end industries.

Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.

The global Oncology Molecular Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncology Molecular Diagnostics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Abbott Laboratories

Bayer Healthcare

Beckton Dickinson

Cepheid

Dako

Danaher

Gen Probe

Qiagen

Roche Diagnostics

Siemens

Sysmex

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

PCR

INAAT

DNA sequencing & NGS

In situ hybridization

DNA microarrays

Other

Market Segment by Applications, can be divided into

Infectious diseases

oncology

Genetic tests

Other

Table of Contents

1 Oncology Molecular Diagnostics Market Overview

1.1 Product Overview and Scope of Oncology Molecular Diagnostics

1.2 Classification of Oncology Molecular Diagnostics by Types

1.2.1 Global Oncology Molecular Diagnostics Revenue Comparison by Types (2017-2023)

1.2.2 Global Oncology Molecular Diagnostics Revenue Market Share by Types in 2017

1.2.3 PCR

1.2.4 INAAT

1.2.5 DNA sequencing & NGS

1.2.6 In situ hybridization

1.2.7 DNA microarrays

1.2.8 Other

1.3 Global Oncology Molecular Diagnostics Market by Application

1.3.1 Global Oncology Molecular Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Infectious diseases

1.3.3 oncology

1.3.4 Genetic tests

1.3.5 Other

1.4 Global Oncology Molecular Diagnostics Market by Regions

1.4.1 Global Oncology Molecular Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Oncology Molecular Diagnostics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncology Molecular Diagnostics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Molecular Diagnostics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Oncology Molecular Diagnostics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Molecular Diagnostics Status and Prospect (2013-2023)

1.5 Global Market Size of Oncology Molecular Diagnostics (2013-2023)

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Business Overview

2.1.2 Oncology Molecular Diagnostics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboratories Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bayer Healthcare

2.2.1 Business Overview

2.2.2 Oncology Molecular Diagnostics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bayer Healthcare Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Beckton Dickinson

2.3.1 Business Overview

2.3.2 Oncology Molecular Diagnostics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Beckton Dickinson Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Cepheid

2.4.1 Business Overview

2.4.2 Oncology Molecular Diagnostics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cepheid Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Dako

2.5.1 Business Overview

2.5.2 Oncology Molecular Diagnostics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Dako Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Danaher

2.6.1 Business Overview

2.6.2 Oncology Molecular Diagnostics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Danaher Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.7 Gen Probe

2.7.1 Business Overview

2.7.2 Oncology Molecular Diagnostics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Gen Probe Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.8 Qiagen

2.8.1 Business Overview

2.8.2 Oncology Molecular Diagnostics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Qiagen Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Roche Diagnostics

2.9.1 Business Overview

2.9.2 Oncology Molecular Diagnostics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Roche Diagnostics Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.10 Siemens

2.10.1 Business Overview

2.10.2 Oncology Molecular Diagnostics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Siemens Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.11 Sysmex

2.11.1 Business Overview

2.11.2 Oncology Molecular Diagnostics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Sysmex Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oncology Molecular Diagnostics Market Competition, by Players

3.1 Global Oncology Molecular Diagnostics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Oncology Molecular Diagnostics Players Market Share

3.2.2 Top 10 Oncology Molecular Diagnostics Players Market Share

3.3 Market Competition Trend

4 Global Oncology Molecular Diagnostics Market Size by Regions

4.1 Global Oncology Molecular Diagnostics Revenue and Market Share by Regions

4.2 North America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

4.3 Europe Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

4.5 South America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

5 North America Oncology Molecular Diagnostics Revenue by Countries

5.1 North America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)

5.2 USA Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

5.3 Canada Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

5.4 Mexico Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

6 Europe Oncology Molecular Diagnostics Revenue by Countries

6.1 Europe Oncology Molecular Diagnostics Revenue by Countries (2013-2018)

6.2 Germany Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

6.3 UK Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

6.4 France Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

6.5 Russia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

6.6 Italy Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Oncology Molecular Diagnostics Revenue by Countries

7.1 Asia-Pacific Oncology Molecular Diagnostics Revenue by Countries (2013-2018)

7.2 China Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

7.3 Japan Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

7.4 Korea Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

7.5 India Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

8 South America Oncology Molecular Diagnostics Revenue by Countries

8.1 South America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)

8.2 Brazil Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

8.3 Argentina Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

8.4 Colombia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Oncology Molecular Diagnostics by Countries

9.1 Middle East and Africa Oncology Molecular Diagnostics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

9.3 UAE Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

9.4 Egypt Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

9.6 South Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

10 Global Oncology Molecular Diagnostics Market Segment by Type

10.1 Global Oncology Molecular Diagnostics Revenue and Market Share by Type (2013-2018)

10.2 Global Oncology Molecular Diagnostics Market Forecast by Type (2018-2023)

10.3 PCR Revenue Growth Rate (2013-2023)

10.4 INAAT Revenue Growth Rate (2013-2023)

10.5 DNA sequencing & NGS Revenue Growth Rate (2013-2023)

10.6 In situ hybridization Revenue Growth Rate (2013-2023)

10.7 DNA microarrays Revenue Growth Rate (2013-2023)

10.8 Other Revenue Growth Rate (2013-2023)

11 Global Oncology Molecular Diagnostics Market Segment by Application

11.1 Global Oncology Molecular Diagnostics Revenue Market Share by Application (2013-2018)

11.2 Oncology Molecular Diagnostics Market Forecast by Application (2018-2023)

11.3 Infectious diseases Revenue Growth (2013-2018)

11.4 oncology Revenue Growth (2013-2018)

11.5 Genetic tests Revenue Growth (2013-2018)

11.6 Other Revenue Growth (2013-2018)

12 Global Oncology Molecular Diagnostics Market Size Forecast (2018-2023)

12.1 Global Oncology Molecular Diagnostics Market Size Forecast (2018-2023)

12.2 Global Oncology Molecular Diagnostics Market Forecast by Regions (2018-2023)

12.3 North America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

12.4 Europe Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

12.6 South America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Oncology Molecular Diagnostics Picture

Table Product Specifications of Oncology Molecular Diagnostics

Table Global Oncology Molecular Diagnostics and Revenue (Million USD) Market Split by Product Type

Figure Global Oncology Molecular Diagnostics Revenue Market Share by Types in 2017

Figure PCR Picture

Figure INAAT Picture

Figure DNA sequencing & NGS Picture

Figure In situ hybridization Picture

Figure DNA microarrays Picture

Figure Other Picture

Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Application (2013-2023)

Figure Oncology Molecular Diagnostics Revenue Market Share by Applications in 2017

Figure Infectious diseases Picture

Figure oncology Picture

Figure Genetic tests Picture

Figure Other Picture

Table Global Market Oncology Molecular Diagnostics Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Oncology Molecular Diagnostics Type and Applications

Table Abbott Laboratories Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer Healthcare Basic Information, Manufacturing Base and Competitors

Table Bayer Healthcare Oncology Molecular Diagnostics Type and Applications

Table Bayer Healthcare Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Beckton Dickinson Basic Information, Manufacturing Base and Competitors

Table Beckton Dickinson Oncology Molecular Diagnostics Type and Applications

Table Beckton Dickinson Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Cepheid Basic Information, Manufacturing Base and Competitors

Table Cepheid Oncology Molecular Diagnostics Type and Applications

Table Cepheid Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Dako Basic Information, Manufacturing Base and Competitors

Table Dako Oncology Molecular Diagnostics Type and Applications

Table Dako Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Danaher Basic Information, Manufacturing Base and Competitors

Table Danaher Oncology Molecular Diagnostics Type and Applications

Table Danaher Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Gen Probe Basic Information, Manufacturing Base and Competitors

Table Gen Probe Oncology Molecular Diagnostics Type and Applications

Table Gen Probe Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Qiagen Basic Information, Manufacturing Base and Competitors

Table Qiagen Oncology Molecular Diagnostics Type and Applications

Table Qiagen Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors

Table Roche Diagnostics Oncology Molecular Diagnostics Type and Applications

Table Roche Diagnostics Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Siemens Basic Information, Manufacturing Base and Competitors

Table Siemens Oncology Molecular Diagnostics Type and Applications

Table Siemens Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Sysmex Basic Information, Manufacturing Base and Competitors

Table Sysmex Oncology Molecular Diagnostics Type and Applications

Table Sysmex Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Players (2013-2018)

Table Global Oncology Molecular Diagnostics Revenue Share by Players (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue Share by Players in 2016

Figure Global Oncology Molecular Diagnostics Revenue Share by Players in 2017

Figure Global Top 5 Players Oncology Molecular Diagnostics Revenue Market Share in 2017

Figure Global Top 10 Players Oncology Molecular Diagnostics Revenue Market Share in 2017

Figure Global Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Regions (2013-2018)

Table Global Oncology Molecular Diagnostics Revenue Market Share by Regions (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue Market Share by Regions (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue Market Share by Regions in 2017

Figure North America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Europe Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure South America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Table North America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)

Table North America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure North America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure North America Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017

Figure USA Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Canada Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Mexico Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Table Europe Oncology Molecular Diagnostics Revenue (Million USD) by Countries (2013-2018)

Figure Europe Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure Europe Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017

Figure Germany Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure UK Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure France Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Russia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Italy Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Oncology Molecular Diagnostics Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017

Figure China Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Japan Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Korea Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure India Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Table South America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)

Table South America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure South America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure South America Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017

Figure Brazil Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Argentina Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Colombia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Oncology Molecular Diagnostics Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure UAE Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Egypt Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure Nigeria Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Figure South Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)

Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Type (2013-2018)

Table Global Oncology Molecular Diagnostics Revenue Share by Type (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue Share by Type (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue Share by Type in 2017

Table Global Oncology Molecular Diagnostics Revenue Forecast by Type (2018-2023)

Figure Global Oncology Molecular Diagnostics Market Share Forecast by Type (2018-2023)

Figure Global PCR Revenue Growth Rate (2013-2018)

Figure Global INAAT Revenue Growth Rate (2013-2018)

Figure Global DNA sequencing & NGS Revenue Growth Rate (2013-2018)

Figure Global In situ hybridization Revenue Growth Rate (2013-2018)

Figure Global DNA microarrays Revenue Growth Rate (2013-2018)

Figure Global Other Revenue Growth Rate (2013-2018)

Table Global Oncology Molecular Diagnostics Revenue by Application (2013-2018)

Table Global Oncology Molecular Diagnostics Revenue Share by Application (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue Share by Application (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue Share by Application in 2017

Table Global Oncology Molecular Diagnostics Revenue Forecast by Application (2018-2023)

Figure Global Oncology Molecular Diagnostics Market Share Forecast by Application (2018-2023)

Figure Global Infectious diseases Revenue Growth Rate (2013-2018)

Figure Global oncology Revenue Growth Rate (2013-2018)

Figure Global Genetic tests Revenue Growth Rate (2013-2018)

Figure Global Other Revenue Growth Rate (2013-2018)

Figure Global Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Oncology Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Oncology Molecular Diagnostics Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

Figure Europe Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

Figure South America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370